Jane Street Group, LLC Insmed Inc Transaction History

Jane Street Group, LLC

$616 Billion
Q3 2025

A detailed history of Jane Street Group, LLC transactions in Insmed Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 791,734 shares of INSM stock, worth $153 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

791,734

Previous 1,352,922 41.48%

Holding current value

$153 Million

Previous $136 Million 16.26%

% of portfolio

0.02%

Previous 0.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$96.14 - $147.2 $54 Million - $82.6 Million	-561,188 Reduced 41.48%	791,734 $114 Million
Q2 2025 Aug 14, 2025	BUY	$64.81 - $105.9 $79.6 Million - $130 Million	1,228,335 Added 985.93%	1,352,922 $136 Million
Q1 2025 May 14, 2025	SELL	$65.25 - $83.83 $9.08 Million - $11.7 Million	-139,134 Reduced 52.76%	124,587 $9.5 Million
Q4 2024 Feb 14, 2025	SELL	$66.29 - $76.63 $26.2 Million - $30.3 Million	-395,954 Reduced 60.02%	263,721 $18.2 Million
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $11.2 Million - $14.2 Million	-180,325 Reduced 21.47%	659,675 $48.2 Million

Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $12.5 Million - $39.7 Million	569,027 Added 209.99%	840,000 $56.3 Million
Q1 2024 May 15, 2024	BUY	$25.72 - $29.94 $4.06 Million - $4.73 Million	157,999 Added 139.85%	270,973 $7.35 Million
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $1.81 Million - $2.46 Million	77,459 Added 218.1%	112,974 $3.5 Million
Q3 2023 Nov 14, 2023	SELL	$19.86 - $26.93 $2.22 Million - $3.02 Million	-112,023 Reduced 75.93%	35,515 $896,000
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $1.44 Million - $1.85 Million	87,684 Added 146.5%	147,538 $3.11 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $718,757 - $960,552	44,204 Added 282.45%	59,854 $1.02 Million
Q4 2022 Feb 14, 2023	SELL	$16.98 - $23.15 $411,051 - $560,415	-24,208 Reduced 60.74%	15,650 $312,000
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $209,468 - $283,002	10,032 Added 33.64%	39,858 $858,000
Q2 2022 Aug 16, 2022	BUY	$17.07 - $25.71 $227,491 - $342,637	13,327 Added 80.77%	29,826 $588,000
Q1 2022 May 17, 2022	SELL	$20.42 - $28.13 $1.18 Million - $1.63 Million	-58,018 Reduced 77.86%	16,499 $388,000
Q4 2021 Feb 15, 2022	BUY	$25.89 - $33.45 $1.26 Million - $1.63 Million	48,584 Added 187.34%	74,517 $2.03 Million
Q3 2021 Nov 16, 2021	SELL	$22.46 - $29.47 $249,058 - $326,792	-11,089 Reduced 29.95%	25,933 $714,000
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $534,664 - $796,577	22,121 Added 148.45%	37,022 $1.05 Million
Q1 2021 May 18, 2021	SELL	$32.28 - $44.3 $1.37 Million - $1.87 Million	-42,296 Reduced 73.95%	14,901 $507,000
Q4 2020 Feb 17, 2021	BUY	$31.45 - $40.54 $800,339 - $1.03 Million	25,448 Added 80.15%	57,197 $1.9 Million
Q3 2020 Nov 17, 2020	SELL	$26.0 - $34.5 $184,158 - $244,363	-7,083 Reduced 18.24%	31,749 $1.02 Million
Q2 2020 Aug 17, 2020	BUY	$14.11 - $29.42 $200,065 - $417,146	14,179 Added 57.51%	38,832 $1.07 Million
Q1 2020 May 15, 2020	BUY	$13.63 - $33.98 $885 - $2,208	65 Added 0.26%	24,653 $395,000
Q4 2019 Feb 14, 2020	SELL	$16.12 - $24.98 $16,651 - $25,804	-1,033 Reduced 4.03%	24,588 $587,000
Q3 2019 Nov 14, 2019	BUY	$15.49 - $25.78 $396,869 - $660,509	25,621 New	25,621 $452,000
Q1 2019 May 16, 2019	SELL	$13.91 - $31.15 $651,989 - $1.46 Million	-46,872 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$11.6 - $18.7 $543,715 - $876,506	46,872 New	46,872 $614,000
Q2 2018 Aug 15, 2018	SELL	$20.0 - $29.72 $269,280 - $400,150	-13,464 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $33,576 - $51,068	1,548 Added 12.99%	13,464 $303,000
Q4 2017 Feb 15, 2018	SELL	$26.43 - $31.78 $34,544 - $41,536	-1,307 Reduced 9.88%	11,916 $372,000
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $153,519 - $412,689	13,223	13,223 $413,000

Others Institutions Holding INSM

# of Institutions

671

Shares Held

209M

Call Options Held

3.83M

Put Options Held

4.26M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $26.2B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Insmed Inc Transaction History